Unlock stock picks and a broker-level newsfeed that powers Wall Street.
PlantX Announces Filing of Restated Financial Statements for the Year Ended March 31, 2021 and Filing of the Annual Financial Statements for the Year Ended March 31, 2022

In This Article:

VANCOUVER, British Columbia, Dec. 23, 2022 (GLOBE NEWSWIRE) -- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company"), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021 (the "Restated Financial Statements") and the filing of its annual financial statements for the year ended March 31, 2022 along with its associated management’s discussion and analysis and related officer certifications (the "Annual Filings"). The Restated Financial Statements and the Annual Filings are available under the Company's SEDAR profile at www.sedar.com.

Highlights for the Year Ended March 31, 2022

The gross revenue for the year ended March 31, 2022 was $11,984,809 (March 2021; $2,885,895).

The cost of goods sold for the year ended March 31, 2022 was $ 8,081,495 (March 2021; $1,996,219)

The net loss for the year ended March 31, 2022 was $54,761,049 (March 2021; $27,770,387), of which $ 10,964,662 (March 2021: $12,339,694) was the result of share-based compensation.

Gross margin for the year was 33% (March 2021: 30%)

Restated Financial Statements for the Year Ended March 31, 2021

During the audit of the Annual Filings, the Company discovered that a supplier and customer in the wholesale division were under the management of the same individual who was also a significant shareholder in both the supplier and customer. As a result of these relationships, the consolidated financial statements for the year ended March 31, 2021, have been restated. The Company purchased inventory for an aggregate consideration of $3,198,172, which was recorded as cost of sales and were sold for an aggregate consideration of $3,700,497, which was recorded as revenue. As a result of these relationships, it was concluded that the sales transactions lacked economic substance and therefore did not meet the IFRS 15 requirements for revenue recognition. Consequently, the net amount of $502,325 is being recognized as part of the “Other Loss” in the restated consolidated statement of loss and comprehensive loss. The Company subsequently ceased transactions relating to its wholesale division as of the first quarter of 2022.

The Restated Financial Statements replace and supersede in their entirety the originally filed audited annual financial statements and management’s discussion and analysis for the year ended March 31, 2021.